Patent: 10,563,264
✉ Email this page to a colleague
Summary for Patent: 10,563,264
| Title: | Methods for assessing risk of developing a viral disease using a genetic test |
| Abstract: | This document provides methods and materials related to treating a disease. For example, this document provides methods for treating a subject\'s disease based on identifying the risk of progressive multifocal leukoencephalopathy PML using a genetic test. |
| Inventor(s): | Hatchwell; Eli (Winchester, GB), Eis; Peggy S. (Fitchburg, WI), Smith, III; Edward B. (New York, NY), Taoufik; Yassine (Paris, FR) |
| Assignee: | PML Screening, LLC (Newport Beach, VA) The Universite Paris-Sud (Orsay, FR) The Assistance Publique--Hopitaux de Paris (APHP) (Paris, FR) The Institut National de la Sante et de la Recherche Medicale (INSERM) (Paris, FR) |
| Application Number: | 16/542,742 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,563,264
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 11/23/2004 | ⤷ Try a Trial | 2037-02-03 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
